Learn More
Medchemexpress LLC Ruxolitinib (S enantiomer) | 941685-37-6 | 99.6% | C17H18N6 | 1 ML

Supplier: Medchemexpress LLC HY50856A10MM/1ML
Ruxolitinib (S enantiomer), also known as S-Ruxolitinib, is the S-enantiomer of Ruxolitinib. It is an orally active and potent JAK inhibitor, targeting the JAK/STAT signaling pathway. This compound is supplied as a 10 mM solution in DMSO, ready for reconstitution.
- Potent JAK inhibitor
- Orally active compound
- Suppresses IFNβ-induced gene expression in human small airway epithelial cells
- Reduces haematopoietic cell expansion in myeloproliferative neoplasms in vivo
- High solubility in DMSO (≥ 100 mg/mL)
- Recommended storage for powder at -20°C for 3 years, and in solvent at -80°C for 2 years
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.